Granulomatous hepatitis after intravesical BCG treatment for bladder cancer.
Article
Dans Anglais
| IMSEAR
| ID: sea-64955
ABSTRACT
Intravesical bacillus Calmette-Guerin (BCG) is used in patients with urinary bladder carcinoma. Although it is generally well tolerated, granulomatous hepatitis is a rare but serious complication. We report a 42-year-old man and a 56-year-old man who developed granulomatous hepatitis following intravesical BCG. One of them was treated successfully with antitubercular therapy; the other died because of BCG sepsis and multi-organ failure.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Tuberculose hépatique
/
Ponction-biopsie à l'aiguille
/
Tumeurs de la vessie urinaire
/
Administration par voie vésicale
/
Humains
/
Mâle
/
Vaccin BCG
/
Carcinome transitionnel
/
Issue fatale
/
Adulte
langue:
Anglais
Année:
2006
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS